Enhancement of solubility and dissolution rate of atorvastatin calcium by co-crystallization
Purpose: To investigate the formation of atorvastatin calcium (AC) co-crystal to improve its solubility and dissolution rate.
Method: Co-crystallization of AC in equimolar ratio with isonicotinamide (INA) was carried out by slow solvent evaporation method using methanol. The solid obtained was characterized by powder x-ray diffraction (PXRD), differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), and then further evaluated for solubility and dissolution.
Results: The PXRD pattern of ACINA showed new crystalline peaks at 2θ values of 8.2 and 18.3o, indicating the presence of a new crystalline phase of ACINA co-crystal. The DSC thermogram of ACINA displayed a melting point at 201.7 oC which is higher than the melting points of AC (159.4 oC) and INA (158.0 oC). The FTIR spectra of AC in ACINA shifted the absorption peak from 3363 to 3280 cm-1 and to 1216 to 1222 cm-1. The absorption peak shift is presumably due to N-H and C-N groups of AC form the hydrogen bonding interaction with groups in INA molecule. The solubility of ACINA co-crystal in distilled water was 270.7 mg/L which is significantly higher (p < 0.05) than that of pure AC (140.9 mg/L). The dissolution rate of ACINA co-crystal was 2 - 3 times faster than that of pure AC.
Conclusion: AC and INA in equimolar ratio forms a co-crystal by slow solvent evaporation. ACINA cocrystal significantly increases in solubility with a dissolution rate 2 - 3 times faster than that of pure AC. The enhancement of aqueous solubility and dissolution rate of AC with co-crystallization may be a potential way to solving the bioavailability problem of AC.
Keywords: Atorvastatin calcium, Co-crystal, Isonicotinamide, Solubility, Dissolution rate
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.